최신약제규정 준수 기사
데이터 요구 사항에서 승인 일정, 라벨링 및 규정 준수에 이르기까지 FDA의 505B1 NDA 프로세스를 탐색하는 방법을 알아보십시오. 전문가의 지도를 받아 지연을 피하십시오.
Read More
더 빠른 FDA 승인을 위해 505B2 NDA 경로를 활용하는 방법을 알아보십시오. 차별화된 의약품에 대해 기존 데이터를 사용하고, 비용을 절감하고, 독점권을 얻으십시오.
Read More
GDUFA 사용자 수수료, 검사 규칙 및 제네릭 의약품 제조사와 CMO를 위한 규정 준수 팁을 이해합니다. 지연을 피하고 더 빠른 미국 시장 접근을 확보하십시오.
Read More
OMUFA에 대한 전체 가이드: OTC 의약품 제조사가 어떻게 FDA 시설 수수료, OMOR, 면제를 관리하고 CARES 법 프레임워크에 따라 규정을 준수할 수 있는지 알아보십시오.
Read More
FDA 및 글로벌 시장에 대한 eCTD 제출을 준비하는 방법을 알아보십시오. 버전 4.0, 수명 주기 팁 및 규정 준수 성공을 위한 모범 사례에 대한 최신 정보를 확인하십시오.
Read More
약제 Regulations FAQ
For Drug Establishments, who must register?
Domestic or foreign owners or operators of establishments that manufacture, prepare, propagate, compound, or process a drug or drugs and are not considered exempt must register their facility with FDA, according to the Code of Federal Regulations. In general, exemptions include pharmacies, professional licensed practitioners, researchers, teachers, analysts, and distributors.
What information is required for drug establishment registration?
Information you must submit as part of your FDA facility registration with your Structured Product Labeling (SPL) file includes:
- Company Name and full address of each establishment
- Name, address, phone number, and email address of official contact
- Type of operation(s) performed at each establishment
- DUNS number
- Facility Establishment Identifier (when assigned)
Non. U.S. establishments must also include:
- Name designated U.S. Agent
- Name of each importer known to the establishmentName of each agent, broker, or other entity, other than a carrier used to facilitate the import of their drug into the U.S.
- Include DUNS number, phone number and email address for each entry.
See Title 21 of the Code of Federal Regulations for a complete list.
Who must provide drug listings?
All drug establishments that are not considered exempt and must register with FDA must also submit initial listing information for all drugs in commercial distribution at the time of their original FDA facility registration, according to the Code of Federal Regulations.
In general, exemptions include pharmacies, professional licensed practitioners, researchers, teachers, analysts, and distributors.
What information is submitted for a drug listing?
Information you must submit as part of your FDA drug listing includes:
- Name of establishment(s) manufacturing or processing the listed drug and the type of operation(s) performed
- DEA schedule
- Route(s) of administration
- Dosage Form
- Ingredients (active with strength amounts and inactive)
- Marketing information (e.g., category, start/stop date)
- Information related to the application (e.g., type and year of approval) or OTC monograph citation number
- Package size and type
- NDC Product Code for a source drug repacked or relabeled
- Unique Ingredient Identifiers (UNII) and other code sets
- Distinctive Characteristics of certain listed drugs
- Labeling artwork
- National Drug Code (NDC) number
What is a master file?
A Master File is a secure, confidential submission of proprietary product data to a regulatory agency, such as the U.S. Food and Drug Administration (FDA), or the National Medical Products Association (NMPA) in China.